{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T04:05:20Z","timestamp":1780632320019,"version":"3.54.1"},"reference-count":67,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T00:00:00Z","timestamp":1653955200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007650","name":"Fundaci\u00f3n Canaria de Investigaci\u00f3n y Salud","doi-asserted-by":"publisher","award":["PI 16\/06"],"award-info":[{"award-number":["PI 16\/06"]}],"id":[{"id":"10.13039\/100007650","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","award":["RTI2018-095061-B-I00"],"award-info":[{"award-number":["RTI2018-095061-B-I00"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012818","name":"Comunidad de Madrid","doi-asserted-by":"publisher","award":["2017-T1\/BMD-5333"],"award-info":[{"award-number":["2017-T1\/BMD-5333"]}],"id":[{"id":"10.13039\/100012818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012818","name":"Comunidad de Madrid","doi-asserted-by":"publisher","award":["PEDJ-2018-POST\/BDM-8900"],"award-info":[{"award-number":["PEDJ-2018-POST\/BDM-8900"]}],"id":[{"id":"10.13039\/100012818","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>Monocytes participate in the development of atherosclerosis through the action of cytokines and other inflammatory mediators. Among them, CCR2 and its ligands, CCL2 and CCL7 play an important role, so the main objective of this work was to determine whether genetic variants affecting their activity were associated with cardiovascular disease. A cohort of 519 patients that have suffered coronary events was analyzed under a propensity score-matching protocol selecting a homogeneous set of cases and controls, according to age, sex, smoking status, dyslipidemia, arterial hypertension and type 2 diabetes as risk factors. While dyslipidemia and arterial hypertension were more prevalent among patients with angina pectoris, current smoking status and elevated inflammatory markers, including total leukocyte and monocyte counts, were more likely associated with acute coronary events. Propensity score matching analysis, performed to eliminate the influence of these risk factors and highlight genetic modifiers, revealed that a single nucleotide variant, rs17735770 at the 3'untranslated region of the CCL7 gene transcript, was associated with decreased cardiovascular risk in a group represented mostly by men, with an average age of 57, and without significant differences in traditional risk factors. Furthermore, the presence of this variant altered the local mRNA structure encompassing a binding site for miR-23ab, resulting in increased translation of a reporter gene in a miR23 independent fashion. The rs17735770 genetic variant led to increased expression of CCL7, a potential antagonist of CCR2 at inflammatory sites, where it could play a meaningful role during the evolution of atherosclerosis.<\/jats:p>","DOI":"10.3389\/fcvm.2022.908070","type":"journal-article","created":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T06:25:42Z","timestamp":1653978342000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["A Common Variant at the 3'untranslated Region of the CCL7 Gene (rs17735770) Is Associated With Decreased Susceptibility to Coronary Heart Disease"],"prefix":"10.3389","volume":"9","author":[{"given":"Jos\u00e9 Mar\u00eda","family":"Medina-Gil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"P\u00e9rez-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Saavedra-Santana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asunci\u00f3n","family":"D\u00edaz-Carrasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efr\u00e9n","family":"Mart\u00ednez-Quintana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fayna","family":"Rodr\u00edguez-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina M.","family":"Ram\u00edrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Ria\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paloma","family":"Garay-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Tugores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,5,31]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1056\/NEJMra1216063","article-title":"Mechanisms of acute coronary syndromes and their implications for therapy","volume":"368","author":"Libby","year":"2013","journal-title":"N Engl J Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1111\/joim.12406","article-title":"Inflammation and plaque vulnerability","volume":"278","author":"Hansson","year":"2015","journal-title":"J Intern Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.cell.2011.04.005","article-title":"Macrophages in the pathogenesis of atherosclerosis","volume":"145","author":"Moore","year":"2011","journal-title":"Cell."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2944","DOI":"10.1111\/febs.14466","article-title":"A guide to chemokines and their receptors","volume":"285","author":"Hughes","year":"2018","journal-title":"FEBS J."},{"key":"B5","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.it.2011.05.001","article-title":"Monocyte trafficking in acute and chronic inflammation","volume":"32","author":"Ingersoll","year":"2011","journal-title":"Trends Immunol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1161\/ATVBAHA.108.180505","article-title":"Regulation of the migration and survival of monocyte subsets by chemokine receptors and its relevance to atherosclerosis","volume":"29","author":"Gautier","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1172\/JCI28549","article-title":"Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques","volume":"117","author":"Tacke","year":"2007","journal-title":"J Clin Invest."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1161\/CIRCULATIONAHA.107.745091","article-title":"Combined inhibition of CCL2, CX3CR1, and CCR5 abrogates Ly6C(hi) and Ly6C(lo) monocytosis and almost abolishes atherosclerosis in hypercholesterolemic mice","volume":"117","author":"Combadi\u00e8re","year":"2008","journal-title":"Circulation."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1172\/JCI119798","article-title":"Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice","volume":"100","author":"Boring","year":"1997","journal-title":"J Clin Invest."},{"key":"B10","doi-asserted-by":"publisher","first-page":"12053","DOI":"10.1073\/pnas.94.22.12053","article-title":"Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2","volume":"94","author":"Kuziel","year":"1997","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B11","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1038\/29788","article-title":"Decreased lesion formation in CCR2-\/- mice reveals a role for chemokines in the initiation of atherosclerosis","volume":"394","author":"Boring","year":"1998","journal-title":"Nature."},{"key":"B12","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0021-9150(98)00318-9","article-title":"Absence of CC chemokine receptor-2 reduces atherosclerosis in apolipoprotein E-deficient mice","volume":"143","author":"Dawson","year":"1999","journal-title":"Atherosclerosis."},{"key":"B13","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1161\/01.ATV.0000058431.78833.F5","article-title":"Transplantation of monocyte CC-chemokine receptor 2-deficient bone marrow into ApoE3-Leiden mice inhibits atherogenesis","volume":"23","author":"Guo","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S1097-2765(00)80139-2","article-title":"Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice","volume":"2","author":"Gu","year":"1998","journal-title":"Mol Cell."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e33497","DOI":"10.1371\/journal.pone.0033497","article-title":"Local gene silencing of monocyte chemoattractant protein-1 prevents vulnerable plaque disruption in apolipoprotein E-knockout mice","volume":"7","author":"Liu","year":"2012","journal-title":"PLoS ONE."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1126\/science.289.5482.1202","article-title":"Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3","volume":"289","author":"McQuibban","year":"2000","journal-title":"Science."},{"key":"B17","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s00109-003-0435-x","article-title":"Chemokine receptor (CCR2) genotype is associated with myocardial infarction and heart failure in patients under 65 years of age","volume":"81","author":"Ortlepp","year":"2003","journal-title":"J Mol Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/sj.gene.6363760","article-title":"Genetic variation at the chemokine receptors CCR5\/CCR2 in myocardial infarction","volume":"2","author":"Gonz\u00e1lez","year":"2001","journal-title":"Genes Immun."},{"key":"B19","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S0021-9150(01)00423-3","article-title":"Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease (CAD). Coincidence of elevated Lp(a) and MCP-1\u22122518 G\/G genotype in CAD patients","volume":"158","author":"Szalai","year":"2001","journal-title":"Atherosclerosis."},{"key":"B20","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1756-0500-3-31","article-title":"CCR2 and coronary artery disease: a woscops substudy","volume":"3","author":"Dow","year":"2010","journal-title":"BMC Res Notes."},{"key":"B21","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1161\/CIRCGENETICS.115.001374","article-title":"Common and rare genetic variation in CCR2, CCR5, or CX3CR1 and risk of atherosclerotic coronary heart disease and glucometabolic traits","volume":"9","author":"Golbus","year":"2016","journal-title":"Circ Cardiovasc Genet."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1161\/01.ATV.0000038486.48400.E7","article-title":"Val64Ile polymorphism in the C-C chemokine receptor 2 is associated with reduced coronary artery calcification","volume":"22","author":"Valdes","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1161\/CIRCULATIONAHA.105.543579","article-title":"CCL2 polymorphisms are associated with serum monocyte chemoattractant protein-1 levels and myocardial infarction in the Framingham Heart Study","volume":"112","author":"McDermott","year":"2005","journal-title":"Circulation."},{"key":"B24","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1253\/circj.70.805","article-title":"Assessment of genetic effects of polymorphisms in the MCP-1 gene on serum MCP-1 levels and myocardial infarction in Japanese","volume":"70","author":"Iwai","year":"2006","journal-title":"Circ J."},{"key":"B25","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.cca.2008.01.004","article-title":"Association between the\u22122518G\/A polymorphism in the monocyte chemoattractant protein-1 (MCP-1) gene and myocardial infarction in Tunisian patients","volume":"390","author":"Jemaa","year":"2008","journal-title":"Clin Chim Acta."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e409","DOI":"10.3275\/7325","article-title":"Insulin resistance explains the relationship between novel cardiovascular risk factors and hypertension. The telde study","volume":"34","author":"W\u00e4gner","year":"2011","journal-title":"J Endocrinol Invest."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1002\/jcph.1144","article-title":"CYP2C19 or CYP3A5 genotyping does not predict clinical response to clopidogrel","volume":"58","author":"Rodr\u00edguez-Gonz\u00e1lez","year":"2018","journal-title":"J Clin Pharmacol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/S0022-2836(05)80360-2","article-title":"Basic local alignment search tool","volume":"215","author":"Altschul","year":"1990","journal-title":"J Mol Biol."},{"key":"B29","unstructured":""},{"key":"B30","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/1471-2105-13-134","article-title":"Primer-BLAST: a tool to design target-specific primers for polymerase chain reaction","volume":"13","author":"Ye","year":"2012","journal-title":"BMC Bioinformatics."},{"key":"B31","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1002\/jcph.275","article-title":"Positive clinical response to clopidogrel is independent of paraoxonase 1 Q192R and CYP2C19 genetic variants","volume":"54","author":"Mart\u00ednez-Quintana","year":"2014","journal-title":"J Clin Pharmacol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1101\/gr.082701.108","article-title":"Most mammalian mRNAs are conserved targets of microRNAs","volume":"19","author":"Friedman","year":"2009","journal-title":"Genome Res."},{"key":"B33","unstructured":""},{"key":"B34","doi-asserted-by":"publisher","first-page":"W70","DOI":"10.1093\/nar\/gkn188","article-title":"The Vienna RNA websuite","volume":"36","author":"Gruber","year":"2008","journal-title":"Nucleic Acids Res"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v064.i09","article-title":"nparcomp: An R software package for nonparametric multiple comparisons and simultaneous confidence intervals","volume":"64","author":"Konietschke","year":"2015","journal-title":"J Stat Softw."},{"key":"B36","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1080\/00401706.1972.10488918","article-title":"Calculation of the residual sum of squares for all possible regressions","volume":"14","author":"Morgan","year":"1972","journal-title":"Technometrics."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v042.i,07","article-title":"Multivariate and propensity score matching software with automated balance optimization: the matching package for R","volume":"42","author":"Sekhon","year":"2011","journal-title":"J Stat Softw."},{"key":"B38","unstructured":"R: A language environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing2016"},{"key":"B39","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.ymthe.2017.11.013","article-title":"miR-23b Suppresses Leukocyte Migration and Pathogenesis of Experimental Autoimmune Encephalomyelitis by Targeting CCL7","volume":"26","author":"Zhang","year":"2018","journal-title":"Mol Ther."},{"key":"B40","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1128\/MCB.00170-19","article-title":"MicroRNA 7 impairs insulin signaling and regulates A\u03b2 levels through posttranscriptional regulation of the insulin receptor substrate 2, insulin receptor, insulin-degrading enzyme, and liver X receptor pathway","volume":"39","author":"Fern\u00e1ndez-de Frutos","year":"2019","journal-title":"Mol Cell Biol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s00011-007-6115-5","article-title":"Optimized THP-1 differentiation is required for the detection of responses to weak stimuli","volume":"56","author":"Park","year":"2007","journal-title":"Inflamm Res."},{"key":"B42","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/978-3-0348-8998-8_2","article-title":"Chemokines as targets for pharmacological intervention","volume":"47","author":"Sozzani","year":"1996","journal-title":"Prog Drug Res."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1161\/CIRCRESAHA.114.302699","article-title":"Inflammation and its resolution as determinants of acute coronary syndromes","volume":"114","author":"Libby","year":"2014","journal-title":"Circ Res."},{"key":"B44","doi-asserted-by":"publisher","first-page":"33","DOI":"10.7326\/0003-4819-55-1-33","article-title":"Factors of risk in the development of coronary heart disease\u2013six year follow-up experience. The Framingham Study","volume":"55","author":"Kannel","year":"1961","journal-title":"Ann Intern Med"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1161\/01.CIR.97.18.1837","article-title":"Prediction of coronary heart disease using risk factor categories","volume":"97","author":"Wilson","year":"1998","journal-title":"Circulation."},{"key":"B46","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/0735-1097(95)00254-2","article-title":"Myocardial infarction in young adults: angiographic characterization, risk factors and prognosis (Coronary Artery Surgery Study Registry)","volume":"26","author":"Zimmerman","year":"1995","journal-title":"J Am Coll Cardiol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1136\/hrt.37.5.493","article-title":"Myocardial infarction in young men. Study of risk factors in nine countries","volume":"37","author":"Dolder","year":"1975","journal-title":"Br Heart J."},{"key":"B48","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.ahj.2004.06.003","article-title":"Impact of age on management and outcome of acute coronary syndrome: observations from the Global Registry of Acute Coronary Events (GRACE)","volume":"149","author":"Avezum","year":"2005","journal-title":"Am Heart J"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1016\/j.cell.2012.03.001","article-title":"Genetics of human cardiovascular disease","volume":"148","author":"Kathiresan","year":"2012","journal-title":"Cell."},{"key":"B50","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1001\/jama.291.18.2204","article-title":"Parental cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults: a prospective study of parents and offspring","volume":"291","author":"Lloyd-Jones","year":"2004","journal-title":"JAMA."},{"key":"B51","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1002\/emmm.201201717","article-title":"Distinct functions of chemokine receptor axes in the atherogenic mobilization and recruitment of classical monocytes","volume":"5","author":"Soehnlein","year":"2013","journal-title":"EMBO Mol Med."},{"key":"B52","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1172\/JCI29919","article-title":"Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites","volume":"117","author":"Tsou","year":"2007","journal-title":"J Clin Invest."},{"key":"B53","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1161\/01.ATV.0000235694.69719.e2","article-title":"Anti-MCP-1 gene therapy inhibits vascular smooth muscle cells proliferation and attenuates vein graft thickening both in vitro and in vivo","volume":"26","author":"Schepers","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.1161\/01.CIR.0000038140.80105.AD","article-title":"Anti-monocyte chemoattractant protein-1 gene therapy limits progression and destabilization of established atherosclerosis in apolipoprotein E-knockout mice","volume":"106","author":"Inoue","year":"2002","journal-title":"Circulation."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1161\/01.RES.0000149518.86865.3e","article-title":"Crucial role of the CCL2\/CCR2 axis in neointimal hyperplasia after arterial injury in hyperlipidemic mice involves early monocyte recruitment and CCL2 presentation on platelets","volume":"95","author":"Schober","year":"2004","journal-title":"Circ Res."},{"key":"B56","unstructured":""},{"key":"B57","doi-asserted-by":"publisher","first-page":"170019","DOI":"10.1098\/rsob.170019","article-title":"SNPs in microRNA target sites and their potential role in human disease","volume":"7","author":"Moszy\u0144ska","year":"2017","journal-title":"Open Biol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"13717","DOI":"10.18632\/oncotarget.7263","article-title":"Single nucleotide polymorphism in the microRNA-199a binding site of HIF1A gene is associated with pancreatic ductal adenocarcinoma risk and worse clinical outcomes","volume":"7","author":"Wang","year":"2016","journal-title":"Oncotarget."},{"key":"B59","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.tcb.2015.07.011","article-title":"The Functions of MicroRNAs: mRNA Decay and Translational Repression","volume":"25","author":"Iwakawa","year":"2015","journal-title":"Trends Cell Biol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"3234","DOI":"10.1073\/pnas.0914825107","article-title":"Role of microRNA-23b in flow-regulation of Rb phosphorylation and endothelial cell growth","volume":"107","author":"Wang","year":"2010","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B61","first-page":"11759","article-title":"miR-23 regulate the pathogenesis of patients with coronary artery disease","volume":"8","author":"Di","year":"2015","journal-title":"Int J Clin Exp Med."},{"key":"B62","doi-asserted-by":"publisher","first-page":"3825","DOI":"10.3390\/jcm10173825","article-title":"Key Chemokine Pathways in Atherosclerosis and Their Therapeutic Potential","volume":"10","author":"M\u00e1rquez","year":"2021","journal-title":"J Clin Med."},{"key":"B63","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1161\/01.CIR.103.16.2096","article-title":"New anti-monocyte chemoattractant protein-1 gene therapy attenuates atherosclerosis in apolipoprotein E-knockout mice","volume":"103","author":"Ni","year":"2001","journal-title":"Circulation."},{"key":"B64","doi-asserted-by":"publisher","first-page":"e0173224","DOI":"10.1371\/journal.pone.0173224","article-title":"Chemokine binding protein 'M3' limits atherosclerosis in apolipoprotein E-\/- mice","volume":"12","author":"Ravindran","year":"2017","journal-title":"PLoS ONE."},{"key":"B65","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.amjcard.2010.11.005","article-title":"Effect of CC chemokine receptor 2 CCR2 blockade on serum C-reactive protein in individuals at atherosclerotic risk and with a single nucleotide polymorphism of the monocyte chemoattractant protein-1 promoter region","volume":"107","author":"Gilbert","year":"2011","journal-title":"Am J Cardiol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"22910","DOI":"10.1038\/srep22910","article-title":"E-selectin-targeting delivery of microRNAs by microparticles ameliorates endothelial inflammation and atherosclerosis","volume":"6","author":"Ma","year":"2016","journal-title":"Sci Rep."},{"key":"B67","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.cmet.2018.05.002","article-title":"Chrono-pharmacological targeting of the CCL2-CCR2 axis ameliorates atherosclerosis","volume":"28","author":"Winter","year":"2018","journal-title":"Cell Metab"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.908070\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T06:25:48Z","timestamp":1653978348000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.908070\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,31]]},"references-count":67,"alternative-id":["10.3389\/fcvm.2022.908070"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2022.908070","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,31]]},"article-number":"908070"}}